Crossmark

MDM2 promotes CELF6 ubiquitination-dependent degradation to promote neuroblastoma cell proliferation

Published Online: 2025-10-21

Authors

Zhao, Zhenzhen

Zhang, Bao

Zhang, Xu

Li, Changchun https://orcid.org/0000-0001-8151-0851
License Information

Text and Data Mining valid from 2025-10-21

Version of Record valid from 2025-10-21
More Information

Article History

Received: 11 April 2025

Revised: 16 August 2025

Accepted: 4 September 2025

First Online: 21 October 2025

Competing interests

: The authors declare no competing interests.

: The studies involving humans were approved by the Institutional Review Board of the Children’s Hospital of Chongqing Medical University. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants’ legal guardians/next of kin.

Document is current